MyD88通过BCAP-PI3K信号传递来决定T细胞的命运
Abraham L Bayer1,2, Zoie Magri1,2, Hayley Muendlein1,2
1Department of Immunology, Tufts University School of Medicine, Boston, MA, United States.
Journal of immunology (Baltimore, Md. : 1950)
|March 12, 2025
概括
MyD88蛋白通过与BCAP相互作用来调节T细胞亡,影响T细胞存活和激活. 这一发现为调节T细胞反应提供了一个新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 效应性T细胞生命周期由T细胞受体 (TCR) 信号控制,决定激活,炎症或亡以解决炎症.
- 髓分化初级反应88 (MyD88) 通常通过收费类受体 (TLR) 促进髓细胞的炎症,但它在T细胞中的作用是不同的,抑制TCR激活和生存.
研究的目的:
- 阐明MyD88在TCR激活和Fas结合后调节T细胞亡的分子机制.
- 为了研究MyD88和B细胞激活蛋白 (BCAP) 在控制T细胞命运中的相互作用.
主要方法:
- 研究了T细胞中MyD88和BCAP在TCR结合和Fasligation后的相互作用.
- 利用MyD88淘汰 (MyD88-/-) T细胞和BCAP淘汰来评估它们对T细胞激活,存活和信号传递的影响.
- 研究了TLR4的脂聚糖 (LPS) 激活对MyD88-BCAP关联和T细胞存活的影响.
主要成果:
- TCR参与上调MyD88和BCAP,促进它们的相互作用并限制BCAP对TCR-BCAP-PI3K-AKT信号的可用性,从而减少T细胞激活和生存.
- MyD88-/- T细胞表现出增强的激活标记,促炎信号和生存率.
- TLR4的脂聚糖 (LPS) 激活破坏了MyD88-BCAP的关联,恢复了野生类型细胞中的T细胞存活率;BCAP敲击消除了MyD88-/-细胞中增强的T细胞表型.
结论:
- MyD88在TCR的下游作用,通过与BCAP的关联来调节T细胞亡和命运.
- 这种相互作用代表了一种控制T细胞生物学的新型分子机制.
- 准MyD88-BCAP相互作用可能为微调T细胞效应器功能和生存提供治疗策略.
相关概念视频
T Cell Activation and Clonal Selection
620
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
620
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
B Cell Activation and Differentiation
1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K
T Cell Types and Functions
740
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
740
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


